<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46-viruses-11-00807">
 <label>46.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martin</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Bakken</surname>
    <given-names>R.R.</given-names>
   </name>
   <name>
    <surname>Lind</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Garcia</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Jenkins</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Glass</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>Parker</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Hart</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Fine</surname>
    <given-names>D.L.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus</article-title>
  <source>Vaccine</source>
  <year>2010</year>
  <volume>28</volume>
  <fpage>3143</fpage>
  <lpage>3151</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.02.056</pub-id>
  <pub-id pub-id-type="pmid">20193792</pub-id>
 </element-citation>
</ref>
